Nonoperating Income (Expense) of Apimeds Pharmaceuticals US, Inc. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Apimeds Pharmaceuticals US, Inc. quarterly and annual Nonoperating Income (Expense) in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Apimeds Pharmaceuticals US, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $62,984.
  • Apimeds Pharmaceuticals US, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $9,354.
  • Apimeds Pharmaceuticals US, Inc. annual Nonoperating Income (Expense) for 2024 was $114,895, a 280% decline from 2023.
Source SEC data
View on sec.gov
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Apimeds Pharmaceuticals US, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $9,354 $62,984 +$95,506 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $104,860 $1,711 +$23,317 01 Apr 2025 30 Jun 2025 10-Q 19 Aug 2025 2025 Q2
Q1 2025 $128,177 $38,029 -$13,282 -54% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025 2025 Q1
Q4 2024 $114,895 $36,020 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
Q3 2024 $32,522 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $21,606 01 Apr 2024 30 Jun 2024 10-Q 19 Aug 2025 2025 Q2
Q1 2024 $24,747 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025 2025 Q1

Apimeds Pharmaceuticals US, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $114,895 -$84,637 -280% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025 2024 FY
2023 $30,258 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.